Payment overview · 2025
General Payments
$98.81
6 reported records · 2 companies
Healthcare provider profile · identity verified
Lloyd Lorenz, MD
Allopathic & Osteopathic Physicians|Family Medicine · PERU, IN · NPI 1255418125
Verified facts
What the public records show
CMS Open Payments records show Lloyd Lorenz, MD received $98.81 in general payments during 2025 across 6 reported records.
Exact Sciences Corporation accounted for 67.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $66.55 | 67.3% | 4 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $32.26 | 32.6% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $98.81 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $66.55 | 4 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $32.26 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 556 | 130 |
| Atorvastatin Calcium | Atorvastatin Calcium | 502 | 128 |
| Lisinopril | Lisinopril | 401 | 120 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 343 | 98 |
| Losartan Potassium | Losartan Potassium | 331 | 78 |
| Amlodipine Besylate | Amlodipine Besylate | 295 | 80 |
| Metformin Hcl | Metformin Hcl | 281 | 79 |
| Pantoprazole Sodium | Pantoprazole Sodium | 273 | 81 |
| Sertraline Hcl | Sertraline Hcl | 241 | 62 |
| Omeprazole | Omeprazole | 238 | 64 |
| Meloxicam | Meloxicam | 233 | 70 |
| Metoprolol Tartrate | Metoprolol Tartrate | 211 | 54 |
| Pravastatin Sodium | Pravastatin Sodium | 203 | 57 |
| Metoprolol Succinate | Metoprolol Succinate | 196 | 59 |
| Alprazolam | Alprazolam | 185 | 43 |
| Pioglitazone Hcl | Pioglitazone Hcl | 184 | 50 |
| Potassium Chloride | Potassium Chloride | 184 | 43 |
| Furosemide | Furosemide | 175 | 56 |
| Trazodone Hcl | Trazodone Hcl | 168 | 47 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 165 | 43 |
| Gabapentin | Gabapentin | 163 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 160 | 45 |
| Tramadol Hcl | Tramadol Hcl | 150 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 142 | 35 |
| Citalopram Hbr | Citalopram Hydrobromide | 132 | 34 |
| Eliquis | Apixaban | 132 | 28 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 127 | 43 |
| Montelukast Sodium | Montelukast Sodium | 123 | 40 |
| Simvastatin | Simvastatin | 123 | 33 |
| Spironolactone | Spironolactone | 123 | 36 |
| Allopurinol | Allopurinol | 120 | 38 |
| Carvedilol | Carvedilol | 115 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 114 | 37 |
| Ezetimibe | Ezetimibe | 95 | 30 |
| Cefuroxime | Cefuroxime Axetil | 94 | 71 |
| Trulicity | Dulaglutide | 90 | 11 |
| Prednisone | Prednisone | 89 | 40 |
| Synthroid | Levothyroxine Sodium | 89 | 19 |
| Glimepiride | Glimepiride | 87 | 24 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 84 | 23 |
| Methylprednisolone | Methylprednisolone | 84 | 70 |
| Mounjaro | Tirzepatide | 77 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 77 | 13 |
| Bupropion Xl | Bupropion Hcl | 75 | 21 |
| Paroxetine Hcl | Paroxetine Hcl | 72 | 15 |
| Bumetanide | Bumetanide | 68 | 12 |
| Atenolol | Atenolol | 65 | 13 |
| Valsartan | Valsartan | 60 | 20 |
| Finasteride | Finasteride | 58 | 14 |
| Ondansetron Odt | Ondansetron | 57 | 24 |
| Repatha Sureclick | Evolocumab | 56 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 54 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 54 | 16 |
| Alendronate Sodium | Alendronate Sodium | 53 | 13 |
| Donepezil Hcl | Donepezil Hcl | 53 | 15 |
| Fenofibrate | Fenofibrate Nanocrystallized | 53 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 53 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 52 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 52 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 52 | 14 |
| Celecoxib | Celecoxib | 50 | 16 |
| Jardiance | Empagliflozin | 48 | 13 |
| Xarelto | Rivaroxaban | 48 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 46 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | 13 |
| Fluconazole | Fluconazole | 45 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | 13 |
| Lansoprazole | Lansoprazole | 44 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 44 | 14 |
| Tresiba Flextouch U-100 | Insulin Degludec | 43 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 42 | 18 |
| Zolpidem Tartrate | Zolpidem Tartrate | 41 | 11 |
| Pregabalin | Pregabalin | 40 | 12 |
| Famotidine | Famotidine | 39 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 38 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 38 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 38 | suppressed |
| Levemir Flexpen | Insulin Detemir | 37 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 37 | 28 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 36 | 28 |
| Metoclopramide Hcl | Metoclopramide Hcl | 36 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 35 | 13 |
| Humalog Kwikpen U-100 | Insulin Lispro | 34 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 34 | 30 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 33 | suppressed |
| Sucralfate | Sucralfate | 32 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 30 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 25 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 27 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 27 | suppressed |
| Mirtazapine | Mirtazapine | 27 | suppressed |
| Clonazepam | Clonazepam | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 23 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 26 | suppressed |
| Memantine Hcl | Memantine Hcl | 26 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Klor-Con M20 | Potassium Chloride | 25 | suppressed |
| Lorazepam | Lorazepam | 25 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 24 | 12 |
| Glipizide | Glipizide | 24 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 23 | suppressed |
| Glipizide Er | Glipizide | 22 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 11 |
| Temazepam | Temazepam | 20 | suppressed |
| Baclofen | Baclofen | 19 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 19 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 19 | suppressed |
| Nystatin | Nystatin | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 18 | suppressed |
| Sotalol | Sotalol Hcl | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | suppressed |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Ramipril | Ramipril | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Olanzapine | Olanzapine | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Klor-Con M10 | Potassium Chloride | 15 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Aliskiren | Aliskiren Hemifumarate | 14 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Praluent Pen | Alirocumab | 14 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 13 | suppressed |
| Humalog | Insulin Lispro | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Risperidone | Risperidone | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Vraylar | Cariprazine Hcl | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Etodolac | Etodolac | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Prolia | Denosumab | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 12 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $98.81 · 6 records | Exact Sciences Corporation | Cologuard Collection Kit, FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error